Deka Bank Deutsche Girozentrale Adaptimmune Therapeutics PLC Transaction History

Deka Bank Deutsche Girozentrale

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$3.5 - $5.68 $147,000 - $238,560	-42,000 Closed	0 $0
Q4 2020 Mar 12, 2021	BUY	$4.0 - $9.2 $168,000 - $386,399	42,000 New	42,000 $215,000
Q3 2019 Nov 14, 2019	SELL	$1.43 - $3.81 $127,270 - $339,090	-89,000 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$3.23 - $5.41 $208,335 - $348,945	64,500 Added 263.27%	89,000 $355,000
Q1 2019 May 10, 2019	SELL	$3.63 - $6.06 $72,600 - $121,199	-20,000 Reduced 44.94%	24,500 $265,000
Q4 2018 Feb 12, 2019	BUY	$3.76 - $14.16 $75,200 - $283,200	20,000 Added 81.63%	44,500 $216,000
Q1 2018 May 03, 2018	BUY	$7.1 - $11.56 $173,950 - $283,220	24,500 New	24,500 $257,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $118M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.